Microglia use TAM receptors to detect and engulf amyloid β plaques.
Youtong HuangKaisa E HapponenPatrick G BurrolaCarolyn O'ConnorNasun HahLing HuangAxel NimmerjahnGreg LemkePublished in: Nature immunology (2021)
Two microglial TAM receptor tyrosine kinases, Axl and Mer, have been linked to Alzheimer's disease, but their roles in disease have not been tested experimentally. We find that in Alzheimer's disease and its mouse models, induced expression of Axl and Mer in amyloid plaque-associated microglia was coupled to induced plaque decoration by the TAM ligand Gas6 and its co-ligand phosphatidylserine. In the APP/PS1 mouse model of Alzheimer's disease, genetic ablation of Axl and Mer resulted in microglia that were unable to normally detect, respond to, organize or phagocytose amyloid-β plaques. These major deficits notwithstanding, TAM-deficient APP/PS1 mice developed fewer dense-core plaques than APP/PS1 mice with normal microglia. Our findings reveal that the TAM system is an essential mediator of microglial recognition and engulfment of amyloid plaques and that TAM-driven microglial phagocytosis does not inhibit, but rather promotes, dense-core plaque development.
Keyphrases
- inflammatory response
- neuropathic pain
- mouse model
- lps induced
- tyrosine kinase
- coronary artery disease
- lipopolysaccharide induced
- cognitive decline
- traumatic brain injury
- genome wide
- poor prognosis
- diabetic rats
- spinal cord injury
- type diabetes
- oxidative stress
- adipose tissue
- drug induced
- single cell
- metabolic syndrome
- skeletal muscle
- long non coding rna
- endothelial cells
- ionic liquid
- wild type